Overall, these FEL profiles validate the ternary complex’s improved energetic and structural stability, reinforcing the hypothesis that dual-targeting of MUC1 by PTX and HNK promotes structural consolidation and could offer enhanced therapeutic efficacy in MUC1-driven cancers. This evidence concerns the gene MUC1 and cancer.